glp 1 market share by company GLP-1 Drugs Size to Hit USD 132.79 Bn 2035 GLP-1 Agonists Market Report 2025-2033,

About 20% of T4 is excreted in the feces, with the remainder eliminated in urine (Eghtedari And Correa 2023)

This can result in significant elevations of heart rate and blood pressure

Micronutrient deficiencies are often higher in people with obesity, and inadequate nutrient intake while using a GLP-1RA may be compounded by already low baseline levels

Training video on the use of the civilian DuoDote autoinjector that contains both atropine and pralidoxime

The lack of regulation, clinical evidence, and the involvement of non-medical professionals in their administration are significant red flags

The study participants were selected by convenience sampling